Endogeny Bio Corp.

Endogeny Bio hopes to exploit the newly discovered regenerative properties of the heart to develop protein therapeutics and small molecules drugs that activate a patient's own multipotential cells to repair damaged heart muscle.

More from Archive

More from Scrip